News
Media
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Advances in the Treatment of Malignant Melanoma

EP. 1: Optimal Management of Locally Advanced Melanoma

ByJeffrey S. Weber, MD, PhD, NYU Langone Health,Sunandana Chandra, MD, Northwestern Medicine,Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center,Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center

June 23rd 2020

EP. 2: Identifying Patients for Neoadjuvant Melanoma Therapy

ByJeffrey S. Weber, MD, PhD, NYU Langone Health,Sunandana Chandra, MD, Northwestern Medicine,Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center,Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center

June 23rd 2020

EP. 3: Molecular Testing in Locally Advanced Melanoma

ByJeffrey S. Weber, MD, PhD, NYU Langone Health,Sunandana Chandra, MD, Northwestern Medicine,Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center,Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center

June 23rd 2020

EP. 4: pCR and Neoadjuvant Therapy for Melanoma

ByJeffrey S. Weber, MD, PhD, NYU Langone Health,Sunandana Chandra, MD, Northwestern Medicine,Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center,Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center

June 23rd 2020

EP. 5: Neoadjuvant Data Explored for Locally Advanced Melanoma

ByJeffrey S. Weber, MD, PhD, NYU Langone Health,Sunandana Chandra, MD, Northwestern Medicine,Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center,Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center

June 23rd 2020

EP. 6: Adjuvant Data Explored for Locally Advanced Melanoma

ByJeffrey S. Weber, MD, PhD, NYU Langone Health,Sunandana Chandra, MD, Northwestern Medicine,Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center,Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center

June 23rd 2020

EP. 7: Adjuvant Therapy for Melanoma: Ongoing Studies of Interest

ByJeffrey S. Weber, MD, PhD, NYU Langone Health,Sunandana Chandra, MD, Northwestern Medicine,Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center,Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center

June 23rd 2020

EP. 8: Adjuvant Therapy for Melanoma: Safety and Efficacy

ByJeffrey S. Weber, MD, PhD, NYU Langone Health,Sunandana Chandra, MD, Northwestern Medicine,Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center,Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center

June 23rd 2020

EP. 9: Systemic Therapy for Metastatic Melanoma

ByJeffrey S. Weber, MD, PhD, NYU Langone Health,Sunandana Chandra, MD, Northwestern Medicine,Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center,Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center

June 23rd 2020

EP. 10: Novel Therapies for Metastatic Melanoma

ByJeffrey S. Weber, MD, PhD, NYU Langone Health,Sunandana Chandra, MD, Northwestern Medicine,Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center,Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center

June 23rd 2020

EP. 11: I/O Dosing Schedules in Metastatic Melanoma

ByJeffrey S. Weber, MD, PhD, NYU Langone Health,Sunandana Chandra, MD, Northwestern Medicine,Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center,Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center

June 23rd 2020

EP. 12: Management of Brain Metastases in Melanoma

ByJeffrey S. Weber, MD, PhD, NYU Langone Health,Sunandana Chandra, MD, Northwestern Medicine,Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center,Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center

June 23rd 2020

EP. 13: Novel Approaches for Relapsed/Refractory Melanoma

ByJeffrey S. Weber, MD, PhD, NYU Langone Health,Sunandana Chandra, MD, Northwestern Medicine,Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center,Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center

June 23rd 2020

EP. 14: Targeted Therapy Versus IO for Relapsed/Refractory Melanoma

ByJeffrey S. Weber, MD, PhD, NYU Langone Health,Sunandana Chandra, MD, Northwestern Medicine,Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center,Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center

June 23rd 2020

EP. 15: Promising Late-Stage Trials in Melanoma

ByJeffrey S. Weber, MD, PhD, NYU Langone Health,Sunandana Chandra, MD, Northwestern Medicine,Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center,Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center

June 23rd 2020

EP. 16: Future Treatment Landscape for Melanoma

ByJeffrey S. Weber, MD, PhD, NYU Langone Health,Sunandana Chandra, MD, Northwestern Medicine,Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center,Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center

June 23rd 2020

EP. 17: Treatment Optimization for Patients With Melanoma

ByJeffrey S. Weber, MD, PhD, NYU Langone Health,Sunandana Chandra, MD, Northwestern Medicine,Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center,Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center

June 23rd 2020

Trending on OncLive

Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer

Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma

Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies

Nuvisertib Yields Strong Safety, Promising Efficacy in R/R Myelofibrosis

FDA Approves Larger Vial Size for Nelarabine Injection in T-ALL and T-LBL